Musashi1 and miR-137 antagonism: impact on neurogenesis and diseases
Musashi1 和 miR-137 拮抗:对神经发生和疾病的影响
基本信息
- 批准号:10064506
- 负责人:
- 金额:$ 42.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-30 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseBiological AssayBiological ProcessBrainBrain NeoplasmsCell CycleCell DeathCell Differentiation processCell Fate ControlCellsClustered Regularly Interspaced Short Palindromic RepeatsCollecting CellComplexDataData SetDevelopmentDiseaseEctopic ExpressionEquilibriumExpression ProfilingGene ExpressionGenesGenomicsGlioblastomaGliomaGoalsHippocampus (Brain)In VitroInfectionLeadMapsMeasuresMemoryMessenger RNAMicroRNAsMitosisMitoticModelingMolecularMorphogenesisMorphologyMusNatureNerve DegenerationNeurodegenerative DisordersNeuronal DifferentiationNeuronsOpen Reading FramesPatternPhenotypePhysiologicalRNA-Binding ProteinsRegulationRoleSubfamily lentivirinaeTAL1 geneTestingTherapeuticTherapeutic InterventionTransfectionTranslationsadult neurogenesisbasecancer cellcell motilitydifferential expressionexperimental studygene repressiongenetic associationgenome-wideimprovedin vivoinhibitor/antagonistnervous system disorderneurogenesisnovel therapeuticsrepairedribosome profilingself-renewalsingle cell sequencingtranscriptome sequencingtumortumorigenesis
项目摘要
Adult neurogenesis is fundamental to brain function with important roles in memory and repair. During
neurogenesis, dramatic physiological and morphological alterations take place due to coordinated changes in
gene expression driven by specific regulators. Dysregulation can ultimately lead to reduced repair,
neurodegenerative diseases and brain tumor development. We identified a molecular switch between self-renewal and differentiation having as central players Musashi1 and miR-137. These regulators have opposite
expression patterns and functions. Musashi1 (Msi1) is a stem-cell protein implicated in self-renewal while miR-137 functions as a neurogenic miRNA. Msi1 and miR-137 interact at two different levels. First, miR-137 represses
Msi1. Second, genomic analyses revealed that Msi1 and miR-137 regulate in opposite directions a large set of
target genes implicated in cell migration, neuronal differentiation and cell morphogenesis.
We propose that the balance between Msi1 and miR-137 is a key factor in cell fate decisions. In our
antagonistic model, Msi1 promotes self-renewal mainly by increasing the expression of targets shared with miR-137 while miR-137 drives differentiation using a double negative switch, inhibiting Msi1 and also the their shared
targets.
In Aim 1, we will use genomic analyses to build an extended regulatory network for Msi1 and miR-137. We
will establish connections (via regulatory, functional or genetic associations) between Msi1/miR-137 shared and
unique targets to other genes displaying changes in expression during neurogenesis and identify other regulators
that potentially function as partners of Msi1 and miR-137. In Aim 2, we will investigate two scenarios relevant to
Alzheimer’s and glioblastoma development: 1) Msi1 inhibition is critical to miR-137 function in differentiation, 2)
if miR-137 high expression is required to maintain the neuronal phenotype and 3) if an increase in Msi1
expression in differentiated cells could trigger cell cycle re-entry and repression of genes that maintain the
neuronal phenotype. Next, to further support our model of antagonism, we will check if inhibition of miR-137
increases Msi1 expression in hippocampal neurons and if the alterations triggered by miR-137 inhibition can be
“neutralized” by silencing Msi1.
成人神经发生是大脑功能的基础,在记忆和修复中起着重要作用。在
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Erzsebet Kokovay其他文献
Erzsebet Kokovay的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Erzsebet Kokovay', 18)}}的其他基金
Opposing Roles for Microglia in the Young and Aged Neurogenic Niche
小胶质细胞在年轻和老年神经源性生态位中的相反作用
- 批准号:
10207796 - 财政年份:2018
- 资助金额:
$ 42.48万 - 项目类别:
Opposing Roles for Microglia in the Young and Aged Neurogenic Niche
小胶质细胞在年轻和老年神经源性生态位中的相反作用
- 批准号:
9750282 - 财政年份:2018
- 资助金额:
$ 42.48万 - 项目类别:
Opposing Roles for Microglia in the Young and Aged Neurogenic Niche
小胶质细胞在年轻和老年神经源性生态位中的相反作用
- 批准号:
10449375 - 财政年份:2018
- 资助金额:
$ 42.48万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 42.48万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 42.48万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 42.48万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 42.48万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 42.48万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 42.48万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 42.48万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 42.48万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 42.48万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 42.48万 - 项目类别: